Global expansion drives $500M valuation for Gene Matrix. Prevents 30K+ adverse drug reactions yearly. US subscription launched. Series A opens soon. We've built a profitable, scalable platform that's ...
CHICAGO, IL, UNITED STATES, October 2, 2025 /EINPresswire.com/ -- Gene Matrix Revolutionizes U.S. Healthcare with AI-Powered Genomics Platform, Announces Major ...